Le produit a bien été ajouté au panier.

discount label
H-FLYALALLL-OH
Vue en 3D

Biosynth logo

H-FLYALALLL-OH

Ref. 3D-PP49844

1mg
217,00 €
10mg
253,00 €
100mg
455,00 €
Livraison estimée en/au États-Unis, le vendredi 27 décembre 2024

Informations sur le produit

Nom :
H-FLYALALLL-OH
Description :

Peptide H-FLYALALLL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FLYALALLL-OH include the following: Activated human γΎ T cells as stimulators of specific CD8+ T-cell responses to subdominant epstein barr virus epitopes: potential for immunotherapy of cancer S Landmeier, B Altvater, S Pscherer - Journal of , 2009 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2009/04000/Activated_Human__gamma__delta__T_Cells_as.11.aspx Presentation of Epstein Barr Virus (EBV) Epitopes by Activated Human γΎ T Cells Induces Peptide-Specific Cytolytic CD8+ T Cell Expansion. S Landmeier, B Altvater, S Pscherer, L Varnholt - 2006 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/108/11/1738/126970 MIX-TPI: a flexible prediction framework for TCR-pMHC interactions based on multimodal representations M Yang, ZA Huang , W Zhou , J Ji , J Zhang , S He - , 2023 - academic.oup.comhttps://academic.oup.com/bioinformatics/article-abstract/39/8/btad475/7234608 A safeguard system for induced pluripotent stem cell-derived rejuvenated T cell therapy M Ando, T Nishimura , S Yamazaki, T Yamaguchi - Stem cell reports, 2015 - cell.comhttps://www.cell.com/stem-cell-reports/pdf/S2213-6711(15)00217-9.pdf Reconstituted complexes of mycobacterial HSP70 and EBV LMP2A-derived peptides elicit peptide-specific cytotoxic T lymphocyte responses and anti-tumor immunity. LGY Liu GenYan, YK Yao Kun, WB Wang Bing - 2011 - cabidigitallibrary.orghttps://www.cabidigitallibrary.org/doi/full/10.5555/20113357801 Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma KC Straathof , AM Leen , EL Buza, G Taylor - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/175/6/4137/73250 Analysis and Development of Antigen-specific T Cells Derived from Peripheral Blood Mononuclear Cells of Healthy Donors J Kim, S Jung, BK Jeong, KA Kim, J Jisu - Anticancer , 2024 - ar.iiarjournals.orghttps://ar.iiarjournals.org/content/44/4/1377.abstract Low dose irradiation increases adoptive cytotoxic T lymphocyte migration in gastric cancer J Du, S Su, H Li, J Shao, F Meng - Experimental and , 2017 - spandidos-publications.comhttps://www.spandidos-publications.com/etm/14/6/5711 Immunotherapy of Epstein-Barr virus associated malignancies using mycobacterial HSP70 and LMP2A356-364 epitope fusion protein G Liu, K Yao, B Wang, Y Chen, F Zhou, Y Guo - Cellular & Molecular , 2009 - nature.comhttps://www.nature.com/articles/cmi200954 Reconstituted complexes of mycobacterial HSP70 and EBV LMP2A-derived peptides elicit peptide-specific cytotoxic T lymphocyte responses and anti-tumor immunity G Liu, K Yao, B Wang, F Zhou, Y Chen, L Li, J Chi - Vaccine, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X1101108X TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein-Barr virus G Lautscham, A Rickinson, N Blake - Microbes and Infection, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1286457903000315 TCRfp: a new fingerprint-based approach for TCR repertoire analysis F Mayol-Rullan, M Bugnon , MAS Perez, V Zoete - bioRxiv, 2023 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2023.12.19.572261.abstract Epstein-Barr Virus Specific Cytotoxic T Cells for Clinical Use in Immune Reconstitution Post Haemopoietic Stem Cell Transplant. E Blyth , LE Clancy, U Sandher, R Khanna, DJ Gottlieb - 2009 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/114/22/2435/63940 The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease CM Bollard , KCM Straathof , MH Huls - Journal of , 2004 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2004/07000/The_Generation_and_Characterization_of.00008.aspx Identification of a TAP-Independent CD Immunoproteasome-Dependent - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=6e874fabd0e772ed11dedd7e21f16b8445ab21e5 Computational prediction and identification of Epstein-Barr virus latent membrane protein 2A antigen-specific CD8+ T-cell epitopes B Wang, K Yao, G Liu, F Xie, F Zhou - Cellular & Molecular , 2009 - nature.comhttps://www.nature.com/articles/cmi200913 NetTCR-2.0 enables accurate prediction of TCR-peptide binding by using paired TCRalpha and beta sequence data A Montemurro , V Schuster , HR Povlsen - Communications , 2021 - nature.comhttps://www.nature.com/articles/s42003-021-02610-3

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP49844 H-FLYALALLL-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".